Correlation Between Neuropace and Accuray Incorporated

Can any of the company-specific risk be diversified away by investing in both Neuropace and Accuray Incorporated at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and Accuray Incorporated into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neuropace and Accuray Incorporated, you can compare the effects of market volatilities on Neuropace and Accuray Incorporated and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of Accuray Incorporated. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and Accuray Incorporated.

Diversification Opportunities for Neuropace and Accuray Incorporated

0.79

Correlation Coefficient

Neuropace  Accuray Incorporated

Poor diversification

The 3 months correlation between Neuropace and Accuray is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and Accuray Incorporated in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Accuray Incorporated and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with Accuray Incorporated. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Accuray Incorporated has no effect on the direction of Neuropace i.e., Neuropace and Accuray Incorporated go up and down completely randomly.

Pair Corralation between Neuropace and Accuray Incorporated

Given the investment horizon of 90 days Neuropace is expected to under-perform the Accuray Incorporated. In addition to that, Neuropace is 1.05 times more volatile than Accuray Incorporated. It trades about -0.36 of its total potential returns per unit of risk. Accuray Incorporated is currently generating about -0.07 per unit of volatility. If you would invest  217.00  in Accuray Incorporated on March 2, 2024 and sell it today you would lose (40.00) from holding Accuray Incorporated or give up 18.43% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Neuropace  vs.  Accuray Incorporated

Neuropace

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Neuropace has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in July 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Accuray Incorporated

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Accuray Incorporated has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in July 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Neuropace and Accuray Incorporated

The main advantage of trading using opposite Neuropace and Accuray Incorporated positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, Accuray Incorporated can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Accuray Incorporated will offset losses from the drop in Accuray Incorporated's long position.

The idea behind Neuropace and Accuray Incorporated pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.